Drug interactions more common and costly for duloxetine
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 27, 2014 Category: Drugs & Pharmacology Source Type: news
Retrospective review of nutmeg toxicity
2.5 out of 5 stars
Nutmeg Poisonings: A Retrospective Review of 10 Years Experience from the Illinois Poison Center: 2001-2011. Ehrenpreis JE et al. J Med Toxicol 2014;10:148-151.
Abstract
Just when you thought it was safe to go back to the eggnog bowl . . .
Nutmeg is the seed of the aromatic evergreen Myristica fragrans. It contains a number of volatile oils, some of which may be metabolized to monoamine oxidase inhibitors or amphetamine-like substances.
Manifestations of nutmeg toxicity are quite similar to those of the anticholinergic syndrome, including dry mouth, flushing, tachycardia, tremor, urinary retention and...
Source: The Poison Review - July 10, 2014 Category: Toxicology Authors: Leon Tags: Medical anticholinergic syndrome myristica fragrans nutmeg Source Type: news
A Cold Splash–Hydrotherapy for Depression and Anxiety
Can hot and cold water help mood? Ancient wisdom and some modern research suggest it may. read more (Source: Psychology Today Anxiety Center)
Source: Psychology Today Anxiety Center - July 6, 2014 Category: Psychiatry & Psychology Authors: Peter Bongiorno, ND, LAc Tags: Anxiety Depression Integrative Medicine Psychiatry alternative medicine cold shower Cymbalta duloxetine electroconvulsive Therapy hippocrates hydrotherapy mood naturopathic medicine naturopathy polar bear club SNRI ssri ant Source Type: news
A Cold Splash - Hydrotherapy for Depression and Anxiety
Can hot and cold water help mood? Ancient wisdom and some modern research suggest it may. read more (Source: Psychology Today Anxiety Center)
Source: Psychology Today Anxiety Center - July 6, 2014 Category: Psychiatry & Psychology Authors: Peter Bongiorno, ND, LAc Tags: Anxiety Depression Integrative Medicine Psychiatry alternative medicine cold shower Cymbalta duloxetine electroconvulsive Therapy hippocrates hydrotherapy mood naturopathic medicine naturopathy polar bear club SNRI ssri ant Source Type: news
Dr Reddy's Lab launches duloxetine delayed-release capsules
Cymbalata (duloxetine delayed- release capsules) brand and generic had US sales of $5.04 billion for the most recent 12 months ending April 2014. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 27, 2014 Category: Pharmaceuticals Source Type: news
Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study - Maund E, Tendal B, Hróbjartsson A, Lundh A, Gøtzsche PC.
OBJECTIVE: To assess the effects of coding and coding conventions on summaries and tabulations of adverse events data on suicidality within clinical study reports. DESIGN: Systematic electronic search for adverse events of suicidality in tables, na... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - June 16, 2014 Category: Global & Universal Tags: Research Methods, Surveillance and Codes, Models Source Type: news
Is Duloxetine more or less effective than Fluoxetine in children and teens with MDD?
(Mary Ann Liebert, Inc./Genetic Engineering News) Two studies of the anti-depressive drug duloxetine, a serotonin-norepinephrine reuptake inhibitor, compared its effectiveness and safety to either fluoxetine or placebo in children and adolescents with major depressive disorder. The results of these first controlled trials of duloxetine in pediatric patients with MDD are published in Journal of Child and Adolescent Psychopharmacology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2014 Category: Global & Universal Source Type: news
Medical Marijuana Rated Much More Effective in Treating Fibromyalgia Symptoms Than Drugs
The three drugs approved for the treatment of fibromyalgia are Cymbalta (Duloxetine); Lyrica (Pregabalin); and Savella (Milnacipran). (Source: Disabled World)
Source: Disabled World - April 21, 2014 Category: Disability Tags: Fibromyalgia Source Type: news
Generic Cymbalta - Is Duloxetine Safe?
In December of 2013 the US Food and Drug Administration approved a generic version of the antidepressant Cymbalta. As the manufacturer's patent expires and the cheaper generic becomes available, it's good news for many. Cymbalta is expensive! (I know, because I take it, and it's the costliest drug in my medication arsenal.)
But close on the heels of this approval comes word from Australia that there have been 21 confirmed cases where patients taking duloxetine - already in use there - in doses from 30 to 120mg/day developed the dangerous condition called serotonin syndrome. In ten additional cases Read Full PostGeneric Cy...
Source: About.com Bipolar Disorder - February 28, 2014 Category: Psychiatry Source Type: news
Adherence to Duloxetine Treatment Published by Dove Medical Press
Adherence among newly initiated duloxetine patients varied modestly across the medical conditions for which it was used.(PRWeb February 12, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11577512.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 12, 2014 Category: Pharmaceuticals Source Type: news
FDA approves first generic versions of antidepressant drug Cymbalta
The U.S. Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, and Torrent Pharmaceuticals Ltd. have received FDA approval to market duloxetine in various strengths. "Health care professionals and consumers can be assured that these FDA-approved generic drugs have met our rigorous standards," said Kathleen Uhl, M.D. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 16, 2013 Category: Consumer Health News Tags: Depression Source Type: news
FDA approves generic versions of antidepressant Cymbalta
WASHINGTON, Dec. 14 (UPI) -- The U.S. Food and Drug Administration approved the first generic versions of Cymbalta, a drug used to treat depression and other conditions, officials say. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 15, 2013 Category: Consumer Health News Source Type: news
FDA Approves Generic Versions of Lilly's Antidepressant Cymbalta
The FDA has granted approval for the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription antidepressant that is currently Eli Lilly's top-selling drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 12, 2013 Category: Pharmaceuticals Source Type: news
FDA OK's Generic Versions of Antidepressant Cymbalta
FDA Approves Generic Versions of Antidepressant Cymbalta (Source: WebMD Health)
Source: WebMD Health - December 12, 2013 Category: Consumer Health News Source Type: news
Sun Pharma gets USFDA nod for anti-depressant drug
The company said its subsidiary has received nod from the US Food and Drug Administration to market Duloxetine Delayed-Release Capsules. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 12, 2013 Category: Pharmaceuticals Source Type: news
